Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Edited by Shih-Shun Chen pptx

256 450 1
Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Edited by Shih-Shun Chen pptx

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA Edited by Shih-Shun Chen Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Edited by Shih-Shun Chen Published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia Copyright © 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Publishing Process Manager Oliver Kurelic Technical Editor Teodora Smiljanic Cover Designer InTech Design Team First published February, 2012 Printed in Croatia A free online edition of this book is available at www.intechopen.com Additional hard copies can be obtained from orders@intechweb.org Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma, Edited by Shih-Shun Chen p. cm. ISBN 978-953-307-867-0 Contents Preface IX Chapter 1 Epigenetics of Nasopharyngeal Carcinoma 1 Zhe Zhang, Fu Chen, Hai Kuang and Guangwu Huang Chapter 2 Pathologic Significance of EBV Encoded RNA in NPC 27 Zhi Li, Lifang Yang and Lun-Quan Sun Chapter 3 Role of the Epstein-Barr Virus ZEBRA Protein and HPV in the Carcinogenesis of Nasopharyngeal Carcinoma 43 Moumad Khalid, Laantri Nadia, Attaleb Mohammed, Dardari R’kia, Benider Abdellatif, Benchakroun Nadia, Ennaji Mustapha and Khyatti Meriem Chapter 4 Chemical Carcinogenesis and Nasopharyngeal Carcinoma 61 Faqing Tang, Xiaowei Tang, Daofa Tian and Ya Cao Chapter 5 Epstein-Barr Virus Serology in the Detection and Screening of Nasopharyngeal Carcinoma 83 Li-Jen Liao and Mei-Shu Lai Chapter 6 Imaging of Nasopharyngeal Carcinoma 95 Michael Chan, Eric Bartlett, Arjun Sahgal, Stephen Chan and Eugene Yu Chapter 7 MRI-Detected Cranial Nerve Involvement in Nasopharyngeal Carcinoma 123 Li Li, Wenxin Yuan, Lizhi Liu and Chunyan Cui Chapter 8 Endocrine Complications Following Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma 133 Ken Darzy VI Contents Chapter 9 Ear-Related Issues in Patients with Nasopharyngeal Carcinoma 155 Wong–Kein Christopher Low and Mahalakshmi Rangabashyam Chapter 10 Update on Medical Therapies of Nasopharyngeal Carcinoma 179 Soumaya Labidi, Selma Aissi, Samia Zarraa, Said Gritli, Majed Ben Mrad, Farouk Benna and Hamouda Boussen Chapter 11 Potential Therapeutic Molecular Targets for Nasopharyngeal Carcinoma 189 Shih-Shun Chen Chapter 12 Nasopharyngeal Cancer – An Expanding Puzzle – Claiming for Answers 227 E. Breda, R. Catarino and R. Medeiros Preface Nasopharyngeal carcinoma (NPC) is different from other pharyngeal cancers because it has a higher prevalence rate among populations living in South-Eastern Asia. The development of NPC is complex and could be induced by many factors, such as genetic susceptibility, Epstein-Barr virus infection, and environmental exposure to carcinogens. Patients with early-stage cancer have the best chance for long-term survival; therefore, early detection is crucial to the successful treatment of cancer. The sensitivity of magnetic resonance imaging or computer tomography for the detection of cancer is extremely high, but because of the small areas of abnormality, early-stage cancer is frequently not detected on these images. Although NPC is extremely radiosensitive, patients also experience spreading to the lymph node and distant metastasis, which makes the disease difficult to control and results in poor prognosis. Radiation can also damage the hypothalamic-pituitary, the thyroid gland, and the ear, which can result in neuro-endocrine abnormalities and ear-related complications after radiotherapy. Improving NPC detection and diagnosis, developing new cancer therapies, and designing better strategies for NPC are all important practical efforts. The aim of this book is to provide an overview of the etiologic factors associated with NPC development, to learn more about the effects of radiotherapy and chemotherapy in NPC patients, to provide vital tools for the diagnosis and detection of NPC, and to understand the molecular mechanism of carcinogenesis, which contributes to the development of targeted treatment for NPC. As the editor, I would like to thank the authors for the high quality of their chapters and for accepting the peer review procedure established for the manual. Finally, I would especially like to thank Oliver Kurelic of the InTech-Open Access Publisher for enabling this project to be realized. I also acknowledge the efforts of the entire staff of the Press who contributed to the editing and production process. I sincerely hope that this book is able to provide valuable advice on professional pursuits. Shih-Shun Chen Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taiwan [...]... Yao, and C Ren 2007 Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma Oncology 72 (5-6):357-63 Zhou, L., W Jiang, C Ren, Z Yin, X Feng, W Liu, Q Tao, and K Yao 2005 Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr 26 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Virus DNA in nasopharyngeal carcinoma. .. carcinoma Cancer Res 61 (10):3877-81 Lo, K W., K F To, and D P Huang 2004 Focus on nasopharyngeal carcinoma Cancer Cell 5 (5):423-8 22 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Lo, K W., Y S Tsang, J Kwong, K F To, P M Teo, and D P Huang 2002 Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma Int J Cancer 98 (5):651-5 Lou, P., W Chen, ... Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population Mol Cancer 10:48 20 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Jeanes, A., C J Gottardi, and A S Yap 2008 Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27 (55):6920-9 Jeltsch, A., and W Fischle 2011 Molecular epigenetics:... 4 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma (Bos 1989) Mutations at residues 12, 13 or 61 might lock Ras protein in the active state, which mediate a variety of biological effects associated with enhanced growth and transformation Ras activity is regulated by cycling between inactive GDP-bound and active GTP-bound forms When GTP-bound, Ras binds to and. .. VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9 Cancer Res 65 (19):8826-35 Sun, D., Z Zhang, N Van do, G Huang, I Ernberg, and L Hu 2007 Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker Oral Oncol 43 (1):82-7 24 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma. .. nasopharyngeal carcinoma Int J Cancer Chan, S L., Y Cui, A van Hasselt, H Li, G Srivastava, H Jin, K M Ng, Y Wang, K Y Lee, G S Tsao, S Zhong, K D Robertson, S Y Rha, A T Chan, and Q Tao 2007 The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas Lab Invest 87 (7):644-50 18 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma. .. could be detected in plasma and buffy coat of NPC patients (Wong et al 2002) Methylated DNA was detectable in plasma of NPC patients before treatment including 46% for CDH1,42% for CDH1, 42% for p16, 20% for DAPK ,20% for p15 and 5% for RASSF1A Aberrantly hypermethylated promoter DNA of at least one of the five genes was detectable in 71% of plasma of NPC patients before treatment Hypermethylated promoter... epigenetic inactivation of WIF1 contributes to the aberrant activation of Wnt pathway and is involved in the pathogenesis of NPC (Chan et al 2007) 6 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Cell cycle and DNA repair Aberrant apoptosis, as in all malignancies, is also required for NPC development Inhibition of apoptosis seems to be critical to NPC tumorigenesis... proliferation, differentiation, and apoptosis, repress NF-kB and AP-1 signaling Induced apoptosis,inhibits (Lu et al 2009) tumor growth specifically in bones Proapoptotic function through the inhibition of PP2A (Yanatatsaneejit et al 2008) 10 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Gene Cancerrelated process CDH1 Invasion and metastasis CDH13 PCDH10 /OL-PCDH... methylation markers not only improved the discrimination between NPC and non-NPC diseases, but also the sensitivity of cancer 16 Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma detection The detection rate can reach 98% when combined analysis of five methylation markers (RASSF1A, p16, WIF1, CHFR and RIZ1) in a recent study (Hutajulu et al 2011) 4.2 Methylation . CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA Edited by Shih-Shun Chen Carcinogenesis,. Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma Edited by Shih-Shun Chen Published by InTech Janeza

Ngày đăng: 23/03/2014, 17:20

Mục lục

    00 preface_ Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma

    01_ Epigenetics of Nasopharyngeal Carcinoma

    02_ Pathologic Significance of EBV Encoded RNA in NPC

    03_ Role of the Epstein-Barr Virus ZEBRA Protein and HPV in the Carcinogenesis of Nasopharyngeal Carcinoma

    04_ Chemical Carcinogenesis and Nasopharyngeal Carcinoma

    05_ Epstein-Barr Virus Serology in the Detection and Screening of Nasopharyngeal Carcinoma

    06_ Imaging of Nasopharyngeal Carcinoma

    07_ MRI-Detected Cranial Nerve Involvement in Nasopharyngeal Carcinoma

    08_ Endocrine Complications Following Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

    09_ Ear-Related Issues in Patients with Nasopharyngeal Carcinoma

Tài liệu cùng người dùng

  • Đang cập nhật ...